loadpatents
name:-0.010941028594971
name:-0.0071628093719482
name:-0.0016520023345947
Aprahamian; Marc Patent Filings

Aprahamian; Marc

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aprahamian; Marc.The latest application filed is for "co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer".

Company Profile
0.8.8
  • Aprahamian; Marc - Heidelberg DE
  • Aprahamian; Marc - Limersheim FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Parovirus having a CpG-enriched genome useful for cancer therapy
Grant 10,098,917 - Raykov , et al. October 16, 2
2018-10-16
Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer
Grant 10,058,591 - Raykov , et al. August 28, 2
2018-08-28
Oncolytic virotherapy for prevention of tumor recurrence
Grant 9,861,669 - Rommelaere , et al. January 9, 2
2018-01-09
Co-Administration of a Parvovirus and a Cytokine for Therapy of Pancreatic Cancer
App 20160082085 - RAYKOV; Zahari ;   et al.
2016-03-24
Co-Administration of a Parvovirus and a Cytokine for Therapy of Pancreatic Cancer
App 20140328798 - Raykov; Zahari ;   et al.
2014-11-06
Parvovirus Cancer Therapy and Combination with Chemotherapy
App 20140234261 - ROMMELAERE; Jean ;   et al.
2014-08-21
Parovirus Having a CpG-Enriched Genome Useful for Cancer Therapy
App 20130344034 - Raykov; Zahari ;   et al.
2013-12-26
Parvovirus having a CPG-enriched genome useful for cancer therapy
Grant 8,535,929 - Raykov , et al. September 17, 2
2013-09-17
Co-administration Of A Parvovirus And A Cytokine For Therapy Of Pancreatic Cancer
App 20130129678 - RAYKOV; Zahari ;   et al.
2013-05-23
Parvovirus cancer therapy and combination with chemotherapy
Grant 8,414,883 - Rommelaere , et al. April 9, 2
2013-04-09
Oncolytic Virotherapy for Prevention of Tumor Recurrence
App 20120237483 - Rommelaere; Jean ;   et al.
2012-09-20
Parvovirus Having a CPG-Enriched Genome Useful for Cancer Therapy
App 20110033425 - Raykov; Zahari ;   et al.
2011-02-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed